Rizatriptan Benzoate Patent Expiration
Rizatriptan Benzoate was first introduced by Organon Llc A Sub Of Organon And Co
Rizatriptan Benzoate Patents
Given below is the list of patents protecting Rizatriptan Benzoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rizafilm | US9301948 | Instantly wettable oral film dosage form without surfactant or polyalcohol | Jul 30, 2034 | Gensco |
| Maxalt-mlt |
US5457895 (Pediatric) | Method of identifying freeze-dried dosage forms |
Apr 01, 2014
(Expired) | Organon |
| Maxalt-mlt | US5457895 | Method of identifying freeze-dried dosage forms |
Oct 01, 2013
(Expired) | Organon |
| Maxalt |
US5298520 (Pediatric) | Triazole containing indole derivatives |
Dec 29, 2012
(Expired) | Organon Llc |
| Maxalt-mlt |
US5298520 (Pediatric) | Triazole containing indole derivatives |
Dec 29, 2012
(Expired) | Organon |
| Maxalt |
US5602162 (Pediatric) | Imidazole, triazole and tetrazole derivatives |
Jul 28, 2012
(Expired) | Organon Llc |
| Maxalt-mlt |
US5602162 (Pediatric) | Imidazole, triazole and tetrazole derivatives |
Jul 28, 2012
(Expired) | Organon |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Rizatriptan Benzoate's patents.
Latest Legal Activities on Rizatriptan Benzoate's Patents
Given below is the list recent legal activities going on the following patents of Rizatriptan Benzoate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Oct, 2023 | US9301948 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Sep, 2019 | US9301948 |
| Patent Issue Date Used in PTA Calculation Critical
| 05 Apr, 2016 | US9301948 |
| Recordation of Patent Grant Mailed Critical
| 05 Apr, 2016 | US9301948 |
| Email Notification Critical
| 17 Mar, 2016 | US9301948 |
| Issue Notification Mailed Critical
| 16 Mar, 2016 | US9301948 |
| Application Is Considered Ready for Issue Critical
| 03 Mar, 2016 | US9301948 |
| Dispatch to FDC | 03 Mar, 2016 | US9301948 |
| Issue Fee Payment Verified Critical
| 01 Mar, 2016 | US9301948 |
| Issue Fee Payment Received Critical
| 01 Mar, 2016 | US9301948 |
Rizatriptan Benzoate's Family Patents
